4-(4-tert-ButoxycarbonylaMino-cyclohexyl)-piperazine-1-carboxylic acid benzyl ester

Safety Information

Symbol(GHS)

Signal word

Warning

Hazard statements

H315：Causes skin irritation

H319：Causes serious eye irritation

Precautionary statements

P264：Wash hands thoroughly after handling.

P264：Wash skin thouroughly after handling.

P280：Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352：IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338：IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P332+P313：IF SKIN irritation occurs: Get medical advice/attention.

P337+P313：IF eye irritation persists: Get medical advice/attention.

Suppliers and manufacturers

• Guangzhou CATO Research Chemicals Inc.
• SuZhou ShiYa Biopharmaceuticals, Inc.
• Zhengzhou Alfachem Co., Ltd.
• SuZhou ShiYa Biopharmaceuticals, Inc.
• MQ (shanghai) Pharmaceuticals Co., Ltd.
• Yujinpharma(Tianjin) Technology Co.,Ltd.
• Bide Pharmatech Ltd.
• Bide Pharmatech Ltd.
• Shanghai Jieshikai Biotechnology Co. , Ltd.
• Huanuo Pharmaceutical Technology (Guangxi) Co., Ltd